Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
|
PL |
|
STRABAG SE
F:XD4
|
AT |
|
Centaurus Energy Inc
XTSX:CTA
|
CA |
|
B
|
Brikor Ltd
JSE:BIK
|
ZA |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
E
|
eBay Inc
XHAM:EBA
|
US |
|
BIOLASE Inc
OTC:BIOL
|
US |
|
Burckhardt Compression Holding AG
SIX:BCHN
|
CH |
|
B
|
Benesse Holdings Inc
F:BE8
|
JP |
Bankruptcy Probability
Biomed Lublin Wytwornia Surowic i Szczepionek SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biomed Lublin Wytwornia Surowic i Szczepionek SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
B
|
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
|
407.5m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biomed Lublin Wytwornia Surowic i Szczepionek SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biomed Lublin Wytwornia Surowic i Szczepionek SA has total debt of 8.4m PLN. This includes both short-term (0 PLN) and long-term (8.4m PLN) debt.
You can find a full breakdown on its Balance Sheet.
